Novo Nordisk and Eli Lilly have dominated the market until now, but this year is set to bring oral drugs, generics, and a ...

The past couple of years have been challenging for the company. But this could be the beginning of a new chapter.

BGE-102 has the potential for therapeutic retinal exposure with oral delivery, reducing treatment burden in ocular indications currently treated with intravitreal therapies Growing preclinical and cli ...

You don't have to sacrifice flavor if you're trying to manage blood sugar levels during the holidays. You can choose from ...

Novo Nordisk entered 2026 with fresh momentum after the U.S. launch of its oral Wegovy pill. Is the stock a buy now?

South Carolinians who wear glasses or contact lenses will have to continue getting fitted for a new prescription at a ...

There are a lot of wonderful doctors who genuinely care, but the stress they face every day, the bureaucracy and heavy ...

Gemini Daily Horoscope Today: You should be ready to take up new risks at the workplace that will lead to career growth.

Friendly” labels on the packaging are becoming more common in U.S. supermarkets as a growing number of Americans ...

These stocks offer impressive long-term upside with downside protection.

It was near John I Leonard High School ...

Background Achondroplasia (ACH), the most common skeletal dysplasia, arises from gain-of-function variants in the fibroblast growth factor receptor 3 gene. Children with ACH experience lifelong ...